Nalu Medical Secures $50 Million Growth Financing to Expand Commercialization of Its Miniature, Battery-Free Neurostimulation System for Chronic Pain

Sep 17, 2025 22:15 CST Updated 22:15

Nalu Medical

Medical Device Developer

Trinity Capital

Equity Investment Firm

Trinity CapitalAnnouncementNalu MedicalProvides up to $50 million in growth funding.

Investor Evaluation

"We are proud to partner with Nalu Medical and support their efforts to improve care for patients with chronic neuropathic pain. We believe Nalu is a leader in the field of peripheral nerve stimulation, reshaping the landscape of pain management through innovative technology and robust clinical data."

---Rob Lake Trinity CapitalSenior Managing Director

Executive Evaluation

"We welcomeTrinity CapitalWe have become financing partners and extend our gratitude for their trust in this important financial arrangement. This funding will support the continued commercial expansion of our newly launched next-generation therapy tray, and deepen our strategic positioning based on the long-term real-world dataset from our recently released permanent PNS device—which we believe is the largest such dataset in the industry—demonstrating reliable long-term pain relief for a broad patient population.

---Tom West Nalu MedicalPresident and Chief Executive Officer

Last month,Nalu MedicalIn the journal "Journal Chronic Pain & Management 》Published on Neurostimulators for the Treatment of Chronic Pain---Nalu NeurostimulationofClinical Study Data (COMFORT 2），Shows passage throughNalu NeurostimulationTreatment provides patients with sustained pain relief.At 6 months of treatment, the trial group achieved an 82% rate of meeting the pain relief target, with a mean pain reduction of 66% (p<0.001), whereas the control group had a target achievement rate of only 4%.

Nalu Neurostimulation

Nalu Neurostimulation It is a neurostimulation product approved by the FDA in 2019, indicated for SCS and PNS applications to treat chronic pain in the back, legs, and neuropathic pain.

Nalu NeurostimulationByIt consists of a fully functional, battery-free, miniature implantable pulse generator (IPG), lead wires, a therapy disc, and a remotely controllable app.Micro-ImplantablePulse emissionImplantable Pulse Generator (IPG)From externalThe wearable treatment tray is wirelessly powered, and throughAPPPerform remote control.

Advantages of Nalu Neurostimulation:

Smaller, Less Invasive Implants: 27 times smaller than the largest commercially available implantable pulse generators (IPGs).
Battery-free miniature IPG: Powered externally via a replaceable, wearable therapy disc, eliminating the need for an implanted battery and battery replacement surgery.
Upgrade Without Surgery: The software can be upgraded wirelessly, without the need for surgery.
Durable Use: Expected service life of 18 years, indicated for the long-term treatment of chronic intractable pain

Nalu Medical

Nalu MedicalNalu Medical, Inc. is an innovative medical device company headquartered in California, focused on developing and commercializing innovative minimally invasive solutions for patients with chronic neuropathic pain.Nalu NeurostimulationDelivers gentle electrical pulses to the nervous system, modulating pain signals before they reach the brain.Nalu NeurostimulationDesigned to address the major unmet needs in the treatment of chronic neuropathic pain and to provide a differentiated value proposition for patients and physicians.